194 related articles for article (PubMed ID: 24916368)
1. Are the antagonists of the renin-angiotensin system also anticancer agents?
Lonati C; Morganti A
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):99-102. PubMed ID: 24916368
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin inhibition and malignancies: a review.
Rosenthal T; Gavras I
J Hum Hypertens; 2009 Oct; 23(10):623-35. PubMed ID: 19339998
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system and cardiovascular risk.
Strauss MH; Hall A
Lancet; 2007 Jul; 370(9581):23-4; author reply 24-5. PubMed ID: 17617258
[No Abstract] [Full Text] [Related]
4. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
Borghi C; ; Rossi F;
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of the renin angiotensin system: proven benefits, unproven safety.
Parfrey PS
Ann Intern Med; 2008 Jan; 148(1):76-7. PubMed ID: 17984483
[No Abstract] [Full Text] [Related]
6. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.
Ponticelli C; Cucchiari D
J Nephrol; 2017 Apr; 30(2):155-157. PubMed ID: 28211033
[No Abstract] [Full Text] [Related]
7. [Dual blockade of the renin-angiotensin system in hypertensive treatment: no].
van der Giet M
Dtsch Med Wochenschr; 2012 Nov; 137(48):2499. PubMed ID: 23168984
[No Abstract] [Full Text] [Related]
8. Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors.
Vistisen ST; Bodilsen J; Scheeren TWL; Simonsen U
Eur J Anaesthesiol; 2020 Sep; 37(9):739-742. PubMed ID: 32769503
[No Abstract] [Full Text] [Related]
9. Hyperkalemia Associated with Renin-Angiotensin-Aldosterone System Inhibition in Patients with Heart Failure; Underexplored and Overrated?
Koratala A; Aboud H; Kazory A
Nephron; 2018; 138(3):220-221. PubMed ID: 29176327
[No Abstract] [Full Text] [Related]
10. Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?
Mallat SG
Cardiovasc Diabetol; 2013 Jul; 12():108. PubMed ID: 23866091
[TBL] [Abstract][Full Text] [Related]
11. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
12. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies.
Yacoub R; Patel N; Lohr JW; Rajagopalan S; Nader N; Arora P
Am J Kidney Dis; 2013 Dec; 62(6):1077-86. PubMed ID: 23791246
[TBL] [Abstract][Full Text] [Related]
13. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
Middeke M
Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
[No Abstract] [Full Text] [Related]
14. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
Werner C; Baumhäkel M; Teo KK; Schmieder R; Mann J; Unger T; Yusuf S; Böhm M
Clin Res Cardiol; 2008 Jul; 97(7):418-31. PubMed ID: 18454336
[TBL] [Abstract][Full Text] [Related]
15. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.
Win TS; Chaiyakunapruk N; Suwankesawong W; Dilokthornsakul P; Nathisuwan S
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):227-35. PubMed ID: 26342120
[TBL] [Abstract][Full Text] [Related]
16. [Angio-oedema and medication that interferes with the renin-angiotensin-aldosterone system--a systematic review].
Suhrs HE; Ibsen H
Ugeskr Laeger; 2012 Mar; 174(11):724-9. PubMed ID: 22409895
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.
Nussberger J; Bohlender J
Nat Rev Cardiol; 2013 Apr; 10(4):183-4. PubMed ID: 23478259
[TBL] [Abstract][Full Text] [Related]
18. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
Chen SS; Seliger SL; Fried LF
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
[TBL] [Abstract][Full Text] [Related]
19. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Gerc V; Buksa M; Loza V; Kulic M
Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
[TBL] [Abstract][Full Text] [Related]
20. Renal outcomes in the ONTARGET study.
Gallieni M; Cozzolino M; Brancaccio D; Giovannini M
Lancet; 2008 Dec; 372(9655):2019; author reply 2020-1. PubMed ID: 19070732
[No Abstract] [Full Text] [Related]
[Next] [New Search]
